1. Hong Kong Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Wai Chun Bio-Technology Ltd.

Wai Chun Bio-Technology Ltd.

HHKEX:660
0.41
HKD
-0.02
(-5.81%)
33.55MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.42
2.5
2.36
2.86
3.14
2.9
3.49
3.42
2.96
- -
4.58
2.16
2.17
- -
Basic EPS, GAAP
-0.2
-0.1
-0.12
-0.24
-0.11
-0.32
-0.02
-0.05
-0.1
- -
-0.09
-0.26
-0.08
- -
Free Cash Flow per Basic Share
0.83
-0.14
-0.06
-0.13
- -
-0.08
0.01
-0.08
-0.06
- -
0.12
0.07
-0.14
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.05
-0.05
-0.16
-0.11
-0.2
-0.29
-0.31
-0.23
-0.32
-0.22
-0.2
-0.46
-0.51
-0.36
Tangible Book Value per Share
0.05
-0.05
-0.16
-0.29
-0.4
-0.47
-0.48
-0.41
-0.5
-0.4
-0.36
-0.61
-0.65
-0.36
Basic Weighted Avg Shares
155
158
160
163
163
166
166
166
167
168
169
171
173
178
Sales/Revenue/Turnover
374
394
377
465
512
481
579
568
495
- -
774
370
377
- -
Operating Margin (%)
-6.52
-4.18
-4.67
-7.99
-3.38
-11.23
2.75
2.01
0.37
- -
1.88
0.39
0.29
- -
Depreciation Expense
3
4
3
4
5
4
5
6
- -
- -
14
11
13
- -
Net Income, GAAP
-31
-16
-20
-39
-17
-54
-3
-8
-17
- -
-15
-44
-15
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
0.83
38.24
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-8.24
-4.03
-5.2
-8.43
-3.4
-11.15
-0.55
-1.44
-3.44
- -
-1.99
-11.95
-3.88
- -
Working Capital
-29
-50
-61
-63
-82
-84
-72
-60
-63
-25
-30
-139
-171
-61
LT Debt
12
18
27
15
25
34
44
51
54
66
71
11
- -
78
Total Equity
32
8
-19
-12
-32
-45
-37
-13
-24
6
11
-55
-63
-35
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
23.57
6.65
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-16.45
-13.82
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
ST Debt
135
95
64
LT Borrowings
12
- -
78
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
171
178
178
Market Capitalization
11
25
34

Working Capital

HKD

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
Total Current Assets
93
107
121
Cash, Cash Equivalents & STI
2
7
6
Accounts Receivable, Net
23
29
50
Inventories
30
57
48
Total Current Liabilities
237
277
183
Payables & Accruals
- -
- -
- -
ST Debt
135
95
64
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-48.78%
-115.64%
13.42%
Free Cash Flow
- -
- -
-304.14%
Net Income, GAAP
- -
- -
-66.93%
Sales/Revenue/Turnover
- -
- -
1.92%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
370
2025
- -
- -
377
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.26
2025
- -
- -
-0.08
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ka Chun Lam
Full Time Employees
61
Sector
Process industries
Industry
Chemicals: major diversified
Address
China Resources Building Hong Kong Hong Kong
IPO Date
Feb 5, 1993
Website
0660.hk
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sale of modified starch and other biochemical products, such as biochemical refined oil products, in the People's Republic of China; it also trades electronic parts, components and electrical appliances, as well as athletic and athlete-style footwear, working shoes, safety shoes, golf shoes, and other functional footwear. Incorporated in 1992 and headquartered at 13/F, Admiralty Centre, Tower II, 18 Harcourt Road, Admiralty, Hong Kong, the company operates production facilities in the PRC serving consumer markets including food processing and industrial applications. Recent developments include a substantial reduction in net loss to HK$14.62 million for the fiscal year ended June 30, 2025, from HK$44.21 million the prior year, driven by lower impairment losses on non-financial assets and revenue growth to HK$377.17 million; a change in head office address announced in early 2025; board changes effective June 5, 2025, including the resignation of a director; an extraordinary general meeting held on September 17, 2025, with a passed resolution; and a revised timetable for capital reorganization and convertible bond alterations, targeting effectiveness by October 28, 2025.